多学科方法管理多发性骨髓瘤相关骨病的专家共识
本共识强调血液科、放射科、骨科等多学科协作管理多发性骨髓瘤相关骨病(MBD),提出利用PET-CT和MRI等影像技术进行早期检测和持续监测,治疗以抗骨髓瘤药物、双膦酸盐和地舒单抗为主,辅以手术和放疗,并注重支持治疗。
要点
- MBD是多发性骨髓瘤常见致残并发症,可导致骨痛、骨折和骨相关事件(SREs)。
- 共识推荐使用PET-CT和MRI等影像技术进行早期检测和持续监测。
- 治疗强调抗骨髓瘤药物、双膦酸盐和地舒单抗的谨慎应用,以降低骨丢失和SRE风险。
核心结论
- 本共识倡导采用标准化、循证的方法管理MBD,确保为患者提供全面协调的诊疗。
研究设计与样本
- 本共识由多学科专家制定,涵盖血液科、放射科、骨科及其他专科,旨在应对MBD的复杂挑战。
诊断标准与关键数值
- 共识强调使用PET-CT和MRI等影像技术进行早期检测和持续监测。
临床应用与阅片要点
- 治疗策略优先考虑谨慎应用抗骨髓瘤药物、双膦酸盐和地舒单抗,以减少骨丢失和降低SRE风险。
- 针对结构性问题或疼痛相关问题,可辅以手术和放疗干预。
- 支持治疗包括疼痛管理、康复、营养支持和牙科评估,对改善患者结局和维持生活质量起关键作用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This consensus on multiple myeloma-related bone diseases (MBDs) underscores the importance of a multidisciplinary approach that encompasses hematology, radiology, orthopedics, and additional specialties to tackle its intricate challenges. MBD, a prevalent and debilitating complication of multiple myeloma, leads to bone pain, fractures, and skeletal-related events (SREs), which profoundly impact patients' quality of life. The guidelines offer a thorough framework for diagnosis, treatment, and continual assessment, emphasizing early detection and consistent monitoring using imaging techniques such as positron emission tomography-computed tomography (PET-CT) and magnetic resonance imaging (MRI). Treatment strategies prioritize the careful application of anti-myeloma agents, bisphosphonates, and denosumab to minimize bone loss and decrease SRE risk, complemented by surgical and radiotherapy interventions for structural or pain-related issues. Supportive care measures, including pain management, rehabilitation, nutritional support, and dental evaluations, play a crucial role in enhancing patient outcomes and preserving quality of life. This consensus advocates a standardized, evidence-based approach to managing MBD, ensuring comprehensive and coordinated care for patients.
引用
- Wang Y, Xu Q, Li Y, et al. Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease. Cancer Pathog Ther. 2024. PMID: 40697511. doi:10.1016/j.cpt.2024.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。